Stock SLRX SALARIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Salarius Pharmaceuticals, Inc.

Equities

SLRX

US79400X3052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.4632 USD +0.37% Intraday chart for Salarius Pharmaceuticals, Inc. -4.26% -28.74%
May. 13 Salarius Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 25 Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data MT

Evolution of the average Target Price on Salarius Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

553641853c69c2012b99044.1sAX2wqxEUBRJGavVz3Tdkf761xnRAupS6_2lplisIk.tJJW6nDCWDc-cAX4FlSRW3G0jzE-cm36D9uZr_IKw---o1aybsN_MRtKAQ~35e002e441c4347e1c0dd31392224bd9

Analyst Recommendations on Salarius Pharmaceuticals, Inc.

HC Wainwright Adjusts Salarius Pharmaceuticals' Price Target to $4 From $5, Reiterates Buy Rating MT
SALARIUS PHARMACEUTICALS : HC Wainwright Starts Salarius Pharmaceuticals at Buy With $5 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.4632 USD
Average target price
3.25 USD
Spread / Average Target
+601.64%
High Price Target
3.25 USD
Spread / Highest target
+601.64%
Low Price Target
3.25 USD
Spread / Lowest Target
+601.64%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Salarius Pharmaceuticals, Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SLRX Stock
  4. Consensus Salarius Pharmaceuticals, Inc.